Overview of Japan’s Pharmaceutical Market in 2024  According to the news (【2024年国内医薬品売上高トップ10】キイトルーダ、1851億円で首位…2位にリクシアナ、「共連れ」のオプジーボは3位 | AnswersNews) released by AnswersNews on 01/27/2025, In 2024, MSD’s immune checkpoint inhibitor, Keytruda, led Japan’s pharmaceutical market with sales reaching ¥185.1 billion. Following closely, Daiichi Sankyo’s anticoagulant, Lixiana, secured the second position with ¥147.7 billion in sales, slightly surpassing Ono Pharmaceutical’s Opdivo, […]